CellCept
Showing 1 - 25 of 464
Infection, Transplant;Failure,Kidney Trial in San Francisco (Mycophenolate Mofetil)
Withdrawn
- Infection
- Transplant;Failure,Kidney
- Mycophenolate Mofetil
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 2, 2022
Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)
Not yet recruiting
- Lupus Nephritis
- Chronic Kidney Diseases
- Dapagliflozin 10mg Tab
- Standard maintenance therapy
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 24, 2023
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS Trial in Paris Cedex 10 (Autologous Hematopoietic Stem Cell Transplantation, Rituximab)
Withdrawn
- REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Autologous Hematopoietic Stem Cell Transplantation
- Rituximab
-
Paris Cedex 10, FranceDept. of Internal Medicine, HĂ´pital Saint-Louis
Sep 21, 2021
Lupus Nephritis Trial in Hong Kong (Tacrolimus, Mycophenolate mofetil)
Recruiting
- Lupus Nephritis
- Tacrolimus
- Mycophenolate mofetil
-
Hong Kong, Hong KongThe University of Hong Kong
May 16, 2022
Cytomegalovirus Infections Trial in Tehran (Everolimus Pill, Sandimmun (Neoral) dose plus cellcept)
Completed
- Cytomegalovirus Infections
- Everolimus Pill
- Sandimmun (Neoral) dose plus cellcept
-
Tehran, Iran, Islamic Republic ofNooshin Dalili
May 27, 2021
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)
Recruiting
- Hepatitis, Drug-Induced
- Mycophenolate Mofetil
- +3 more
-
Herlev, Copenhagen, Denmark
- +4 more
Dec 11, 2022
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)
Recruiting
- Hematologic Malignancies
- CliniMACS® CD34 Reagent System
- +7 more
-
Chicago, Illinois
- +1 more
Sep 20, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)
Not yet recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Mycophenolate Mofetil
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
May 17, 2022
Pemphigus Vulgaris Trial in Wuhan (Abatacept Prefilled Syringe, Mycophenolate Mofetil 500Mg Tab)
Recruiting
- Pemphigus Vulgaris
- Abatacept Prefilled Syringe
- Mycophenolate Mofetil 500Mg Tab
-
Wuhan, Hubei, ChinaTongji Hospital
Mar 20, 2022
Kidney; Complications, Allograft, Transplantation Infection Trial in Loma Linda (Immunosuppressive Agents)
Active, not recruiting
- Kidney; Complications, Allograft
- Transplantation Infection
- Immunosuppressive Agents
-
Loma Linda, CaliforniaLoma Linda University Medical Center, Transplantation Institute
Apr 28, 2022
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)
Terminated
- Sickle Cell Disease
- Alemtuzumab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 28, 2022
Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate
Not yet recruiting
- Lung Transplant; Complications
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 6, 2022
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Autoimmune Hepatitis Trial in Netherlands (Mycophenolate Mofetil, Tacrolimus)
Recruiting
- Autoimmune Hepatitis
- Mycophenolate Mofetil
- Tacrolimus
-
Delft, Netherlands
- +5 more
Jan 21, 2022